Palisade Capital Management LLC Paratek Pharmaceuticals, Inc. Transaction History

Palisade Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$4.19 - $6.69 $62,012 - $99,012	-14,800 Closed	0 $0
Q2 2020 Aug 06, 2020	SELL	$2.97 - $5.22 $8,910 - $15,660	-3,000 Reduced 16.85%	14,800 $77,000
Q1 2020 May 13, 2020	SELL	$2.67 - $4.97 $61,410 - $114,310	-23,000 Reduced 56.37%	17,800 $56,000
Q4 2019 Feb 04, 2020	BUY	$2.93 - $4.5 $119,544 - $183,600	40,800 New	40,800 $164,000
Q4 2018 Feb 12, 2019	SELL	$4.8 - $11.6 $62,400 - $150,800	-13,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$9.05 - $10.95 $117,650 - $142,350	13,000 New	13,000 $126,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Palisade Capital Management LLC with notifications on news.